Keystone Wealth Services LLC Invests $315,000 in Prestige Consumer Healthcare Inc. $PBH

Key Points

• Keystone Wealth Services LLC has acquired a new stake in Prestige Consumer Healthcare Inc., purchasing 3,951 shares valued at approximately $315,000 during the second quarter.
• Institutional investors own 99.95% of Prestige Consumer Healthcare's stock, reflecting strong interest from large financial entities.
• The company reported earnings of $0.95 per share, missing estimates, and its revenue decreased by 6.6% year-over-year to $249.53 million.

Keystone Wealth Services LLC purchased a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 3,951 shares of the company's stock, valued at approximately $315,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Cerity Partners LLC increased its holdings in shares of Prestige Consumer Healthcare by 3.7% in the 1st quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock valued at $315,000 after acquiring an additional 132 shares during the last quarter. KBC Group NV grew its position in Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after purchasing an additional 151 shares during the last quarter. McIlrath & Eck LLC grew its stake in shares of Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after purchasing an additional 154 shares during the last quarter. Xponance Inc. grew its position in Prestige Consumer Healthcare by 5.5% in the 1st quarter. Xponance Inc. now owns 3,766 shares of the company's stock valued at $324,000 after buying an additional 196 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. boosted its holdings in shares of Prestige Consumer Healthcare by 2.3% in the first quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company's stock valued at $783,000 after acquiring an additional 203 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

PBH has been the topic of a number of analyst reports. Zacks Research downgraded Prestige Consumer Healthcare from a "hold" rating to a "strong sell" rating in a research note on Thursday, September 4th. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Canaccord Genuity Group decreased their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $93.33.

Prestige Consumer Healthcare Trading Down 1.5%

Shares of Prestige Consumer Healthcare stock traded down $0.99 during trading hours on Friday, reaching $63.11. The stock had a trading volume of 1,033,476 shares, compared to its average volume of 567,570. The firm has a 50 day simple moving average of $69.07 and a two-hundred day simple moving average of $78.44. The firm has a market capitalization of $3.11 billion, a price-to-earnings ratio of 14.81, a P/E/G ratio of 1.99 and a beta of 0.46. The company has a current ratio of 4.38, a quick ratio of 2.99 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a 1 year low of $61.93 and a 1 year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). Prestige Consumer Healthcare had a net margin of 19.02% and a return on equity of 12.69%. The business had revenue of $249.53 million during the quarter, compared to analysts' expectations of $260.71 million. During the same period in the prior year, the business posted $0.90 EPS. The business's revenue was down 6.6% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.